NCT07619521
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
- Yale University Cancer Center LAO New Haven, Connecticut, United States
Clinical trial condition
Advanced Pancreatic Ductal Adenocarcinoma
Explore clinical trials studying Advanced Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
8 public trials
3 recruiting studies
Advanced Pancreatic Ductal Adenocarcinoma trial results
NCT07408505
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Body Weight, Cancer Anorexia-Cachexia Syndrome, +2 more
- Locations
-
- Jinan, Shandong 0531 Jinan, China
NCT06825546
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma
- Locations
-
- Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
- Henan Provincial People's Hospital Zhengzhou, Henan, China
- Hubei Cancer Hospital Wuhan, Hubei, China
- Hunan Provincial People's Hospital Changsha, Hunan, China
Not yet recruiting
ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.
NCT07348107
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Verspeeten Family Cancer Centre London, Ontario, Canada
Active, not recruiting
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
NCT04887805
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +12 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
NCT07021066
- Conditions
- Adenocarcinoma Of Esophagus, Advanced Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer, +9 more
- Locations
-
- HonorHealth Scottsdale, Arizona, United States
- Valkyrie Clinical Trials Los Angeles, California, United States
- University of Colorado Health Aurora, Colorado, United States
- Yale Cancer Center New Haven, Connecticut, United States
Active, not recruiting
AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC
NCT05632328
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +8 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Active, not recruiting
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
NCT02921022
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Cardiovascular Diseases, Digestive System Diseases, +11 more
- Locations
-
- Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
- Miami Cancer Institute Miami, Florida, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States